Pathological evaluation of the tumor using histopathological features (Figure 2) showed diffuse immunoreactivity for oligodendrocyte transcription factor 2 (OLIG-2), weak to moderate immunoreactivity for neuronal nuclear protein (Neu-N), and focal immunoreactivity for CD56. Here, OLIG2 is linked to neoplasm.